CHIPTS
Advancing HIV research for better prevention and treatment services, with dedicated support through email and phone.
Advancing HIV research for better prevention and treatment services, with dedicated support through email and phone.
CHIPTS, or the Center for HIV Identification, Prevention, and Treatment Services, is a pioneering initiative with the mission of advancing HIV research to enhance prevention and treatment services. Established in 1997, CHIPTS is a collaboration between renowned researchers from UCLA, Charles Drew University of Medicine and Science, Friends Research Institute, and the RAND Corporation. Supported by the National Institutes of Mental Health, the primary goal is to eliminate new HIV infections by facilitating collaborative research, networking, and capacity building, especially focusing on key populations with comorbidities.
Noteworthy for its expertise in program administration, faculty development, policy impact evaluation, and innovative interventions, CHIPTS plays a significant role in not only enhancing the care and treatment of HIV-infected individuals but also expanding prevention opportunities for at-risk populations, both domestically and globally.
With its headquarters in the United States, CHIPTS received a significant $2.10M grant investment from the National Institutes of Health, marking the latest milestone in its journey to revolutionize HIV research and support services.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $2.10M | 1 | National Institutes of Health | 02 Nov 2023 |
No recent news or press coverage available for CHIPTS.
We care about your data, and we'd love to use cookies make your experience better.